Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Accounts Payables (2017 - 2025)

Historic Accounts Payables for Catheter Precision (VTAK) over the last 9 years, with Q3 2025 value amounting to $1.1 million.

  • Catheter Precision's Accounts Payables rose 5240.11% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year increase of 5240.11%. This contributed to the annual value of $230000.0 for FY2024, which is 5043.1% down from last year.
  • As of Q3 2025, Catheter Precision's Accounts Payables stood at $1.1 million, which was up 5240.11% from $804000.0 recorded in Q2 2025.
  • Catheter Precision's 5-year Accounts Payables high stood at $1.2 million for Q1 2022, and its period low was $92000.0 during Q4 2022.
  • Its 5-year average for Accounts Payables is $628157.9, with a median of $580000.0 in 2023.
  • Its Accounts Payables has fluctuated over the past 5 years, first tumbled by 9068.83% in 2022, then skyrocketed by 78924.73% in 2024.
  • Quarter analysis of 5 years shows Catheter Precision's Accounts Payables stood at $988000.0 in 2021, then plummeted by 90.69% to $92000.0 in 2022, then skyrocketed by 404.35% to $464000.0 in 2023, then crashed by 50.43% to $230000.0 in 2024, then surged by 369.13% to $1.1 million in 2025.
  • Its Accounts Payables stands at $1.1 million for Q3 2025, versus $804000.0 for Q2 2025 and $647000.0 for Q1 2025.